Empagliflozin therapy and insulin resistance-associated disorders: effects and promises beyond a diabetic state.

Arch Med Sci Atheroscler Dis · 2021 · PMC8117073 · PMID 34027215

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

There was a clear trend towards body weight reduction in the empagliflozin arm, which became significant after 1 and 2 weeks of therapy.

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.